Platelet News and Research

RSS

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

Whenever an organism is damaged, the cells surrounding the wound receive signals to proliferate more intensely so as to regenerate the injured tissue.

26 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Nutrition researchers outline cardiometabolic benefits of plant-based eating patterns

Plant-based eating patterns continue to soar in popularity and a group of nutrition researchers outlines the science behind this sustainable trend in a review paper, entitled "Cardiometabolic benefits of plant-based diets," which appears as an online advance in the Aug. 9, 2017, edition of Nutrients.

11 Aug 2017

New study reveals how glucose metabolism affects platelet activation and survival

Platelets, the cells in blood that enable clotting, are highly reliant on their ability to metabolize glucose, according to a new study by researchers at the University of Iowa.

4 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

Researchers detect new gene mutation linked to Fanconi anemia

Fanconi anemia is a rare genetic disease characterized by bone marrow failure heralded by low platelet counts and unusually large red blood cells.

14 Jul 2017

Erectile dysfunction drug may be used to coat stents in future heart surgeries

Coating stents with an erectile dysfunction drug may be the way forwards in treating stent patients, say researchers.

12 Jul 2017

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

A widely used screening tool deployed in the early phases of drug discovery to weed out undesirable compounds is wrong so often it can't be trusted on its own, according to scientists at the University of North Carolina at Chapel Hill.

11 Jul 2017

American Red Cross is facing blood shortage and urging donors to come forth

The American Red Cross issued an emergency statement early this week that they are facing a shortage of blood and are urging willing donors to come forth and donate blood or platelets as soon as possible.

6 Jul 2017

Novel small molecule tracer for PET imaging spots blood clots

Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality.

6 Jul 2017

Grape consumption leads to better health

A newly released book titled Grapes and Health: A Monograph offers a thorough review of the current science linking the consumption of grapes to better health.

30 Jun 2017

Regular intake of Aspirin in elderly could mean higher than previously thought risk of bleeding says new study

New research shows that the use the antiplatelet drug Aspirin over long term among elderly is fraught with more risks than earlier believed.

14 Jun 2017

Therapeutic small molecules safely prevent blood clots without excessive bleeding

It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.

31 May 2017

Researchers discover new anti-thrombotic drug target for developing more protective blood thinners

Blood platelets shore up open wounds and help cuts heal, but they can also cause heart attacks and strokes when a congealed ball of platelets known as a thrombus breaks free from a site of injury and gets lodged in blood vessels that feed oxygen to the brain or heart.

24 May 2017

Researchers urge caution in treating injured young athletes with cell-based therapies

Physicians, parents and coaches should be cautious when considering treating injured young athletes with platelet rich plasma (PRP), stem cells or other types of regenerative medicine, says a nationally recognized sports medicine clinician and researcher at the University of Miami Miller School of Medicine and UHealth Sports Medicine Institute.

22 May 2017

Platelet News and Research

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Nutrition researchers outline cardiometabolic benefits of plant-based eating patterns

New study reveals how glucose metabolism affects platelet activation and survival

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

Researchers detect new gene mutation linked to Fanconi anemia

Erectile dysfunction drug may be used to coat stents in future heart surgeries

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

American Red Cross is facing blood shortage and urging donors to come forth

Novel small molecule tracer for PET imaging spots blood clots

Grape consumption leads to better health

Regular intake of Aspirin in elderly could mean higher than previously thought risk of bleeding says new study

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Researchers discover new anti-thrombotic drug target for developing more protective blood thinners

Researchers urge caution in treating injured young athletes with cell-based therapies

New discovery may be key to stopping shortages of vital blood-clotting cells

New study aims to test safety and efficacy of antiplatelet drug in preventing blood clots

Study of interactions between chemokines pinpoints potential targets for treatment of inflammation

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News